Maintenance fees coming due
16 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Nov 30, 2026. Unpaid by Jun 1, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,661,457 | IGF-1R Antibody-Drug-Conjugate and Its Use for the Treatment of Cancer In force Fee due Nov 30, 2026 Lapses if unpaid Jun 1, 2027 · High confidence | Pierre Fabre Medicament | In force | Nov 30, 2026 | Jun 1, 2027 | High confidence | |
| US 10,314,921 | Antibody-Drug-Conjugate and Its Use for the Treatment of Cancer In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Pierre Fabre Medicament | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 11,673,931 | Immunocytokines for the Treatment of Cancer In force Fee due Dec 13, 2026 Lapses if unpaid Jun 14, 2027 · High confidence | Pierre Fabre Medicament | In force | Dec 13, 2026 | Jun 14, 2027 | High confidence | |
| US 9,120,852 | Novel Antibody for the Diagnosis And/Or Prognosis of Cancer In force Fee due Mar 1, 2027 Lapses if unpaid Sep 1, 2027 · High confidence | Pierre Fabre Medicament | In force | Mar 1, 2027 | Sep 1, 2027 | High confidence | |
| US 10,414,823 | ANTI-C10ORF54 Antibodies and Uses Thereof In force Fee due Mar 17, 2027 Lapses if unpaid Sep 17, 2027 · High confidence | Pierre Fabre Medicament | In force | Mar 17, 2027 | Sep 17, 2027 | High confidence | |
| US 10,421,818 | ANTI-C10ORF54 Antibodies and Uses Thereof In force Fee due Mar 24, 2027 Lapses if unpaid Sep 24, 2027 · High confidence | Pierre Fabre Medicament | In force | Mar 24, 2027 | Sep 24, 2027 | High confidence | |
| US 10,450,299 | Substituted Quinazoline Derivatives as DNA Methyltransferase Inhibitors Centre National de la Recherche Scientifique (CNRS), Pierre Fabre Medicament and Sapienza Universita Di Roma In force Fee due Apr 22, 2027 Lapses if unpaid Oct 22, 2027 · High confidence | Centre National de la Recherche Scientifique (CNRS), Pierre Fabre Medicament and Sapienza Universita Di Roma | In force | Apr 22, 2027 | Oct 22, 2027 | High confidence | |
| US 10,457,734 | IGF-1R Antibody and Its Use for the Diagnosis of Cancer In force Fee due Apr 29, 2027 Lapses if unpaid Oct 29, 2027 · High confidence | Pierre Fabre Medicament | In force | Apr 29, 2027 | Oct 29, 2027 | High confidence | |
| US 9,173,962 | Novel Antigen Binding Protein and Its Use as Addressing Product for the Treatment of Cancer In force Fee due May 3, 2027 Lapses if unpaid Nov 3, 2027 · High confidence | Pierre Fabre Medicament | In force | May 3, 2027 | Nov 3, 2027 | High confidence | |
| US 10,517,863 | Trilobine and Its Natural Analogs for Use as a Drug In force Fee due Jun 30, 2027 Lapses if unpaid Jan 3, 2028 · High confidence | Pierre Fabre Medicament and Centre National de la Recherche Scientifique (CNRS) | In force | Jun 30, 2027 | Jan 3, 2028 | High confidence | |
| 6 more maintenance fees coming due in the 12 months from Nov 18, 2026 · Pro | |||||||
10 of 16 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.